• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Assertio Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    3/12/25 4:05:17 PM ET
    $ASRT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ASRT alert in real time by email
    asrt-20250312
    0001808665false00018086652025-03-122025-03-12

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
     
    Form 8-K
     
    CURRENT REPORT
    PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
     
    Date of Report (Date of earliest event reported):  March 12, 2025
     
    ASSERTIO HOLDINGS, INC.
    (Exact name of registrant as specified in its charter)
     
    Delaware 001-39294 85-0598378
    (State or Other Jurisdiction of
    Incorporation)
     (Commission File Number) (IRS Employer Identification No.)
     
    100 S. Saunders Road, Suite 300, Lake Forest, IL 60045
    (Address of Principal Executive Offices; Zip Code)
     
    (224) 419-7106
    (Registrant’s telephone number, including area code)
     
    Not Applicable
    (Former Name or Former Address, if Changed Since Last Report)

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class:    Trading Symbol(s):Name of each exchange on which registered:
    Common Stock, $0.0001 par value ASRT
    The Nasdaq Stock Market LLC
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     
    ☐                                    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
    ☐                                    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
    ☐                                    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
    ☐                                    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
     
    Emerging growth company ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o



    Item 2.02Results of Operations and Financial Condition
    On March 12, 2025, Assertio Holdings, Inc. (the “Company”) issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 31, 2024. The press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
     
    The information in Item 2.02 of this Current Report on Form 8-K shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. The information contained herein shall not be incorporated by reference into any filing with the Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

    Item 9.01Financial Statements and Exhibits
    (d) Exhibits
    Exhibit NumberDescription
    99.1
    Assertio Holdings, Inc. Press Release issued on March 12, 2025
    104Cover Page Interactive Data File (embedded within the Inline XBRL document)





    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
     ASSERTIO HOLDINGS, INC.
       
    Date: March 12, 2025By:/s/ Brendan P. O'Grady
      Brendan P. O'Grady
      Chief Executive Officer
    (Principal Executive Officer)

    Get the next $ASRT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ASRT

    DatePrice TargetRatingAnalyst
    7/26/2024$3.00Buy
    Maxim Group
    7/3/2024$4.00Buy
    H.C. Wainwright
    11/7/2022$7.00Buy
    Lake Street
    More analyst ratings